Quality of care for locally advanced and metastatic urothelial carcinoma in Germany
This Medudy course is a video tutorial for physicians on the topic of "Quality of care for locally advanced and metastatic urothelial carcinoma in Germany." Prof. Dr. Carsten Ohlmann, Chief Physician of the Department of Urology at the Johanniter-Kliniken Bonn, presents real treatment data and recommendations for guideline-based care. The course highlights the therapeutic challenges of locally advanced and metastatic urothelial carcinoma, [...]
ARLDD: Mechanism of action & the rechARge study
The Medudy course on ARLDDs and the rechARge study, presented by Professor Axel Merseburger, Director of the Department of Urology at the University of Lübeck, provides practical knowledge on a novel therapeutic approach to metastatic castration-resistant prostate cancer (mCRPC). This unit introduces the novel mechanism of action of androgen receptor ligand-directed degraders (ARLDDs). Particular attention is paid to the first-in-class […]
Lp(a) as a cardiovascular risk factor
This Medudy course is a five-part video series for physicians on the topic of "Lp(a) as a cardiovascular risk factor." We begin with a brief introduction to the background and relevance of the topic. Part 1 then deals with Lp(a) as an independent, causally genetically determined cardiovascular risk factor. In Part 2, we then focus on the structure of the Lp(a) molecule [...].
Arterial hypertension
This Medudy Master Class Series is a video tutorial for physicians on nephrological topics. This two-part module focuses on arterial hypertension and is presented by Prof. Dr. Jan-Christoph Galle, Director of the Clinic for Nephrology and Dialysis at Lüdenscheid Hospital. The first part of the course provides an overview of arterial hypertension from a nephrological perspective [...].
Test Course
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, [...]
Part 6 Therapy management of antibody-drug conjugates (ADC)
This Medudy Master Class Series with Prof. Sherko Kümmel is a video tutorial for physicians on the topic "Therapy of Triple-Negative Breast Cancer". Part 6 of the tutorial focuses on the therapy management of antibody-drug conjugates (ADC). The focus is on the use and handling of substances such as sacituzumab-govitecan and trastuzumab-deruxtecan. The tutorial also provides [...]
Part 5 Metastatic TNBC
This Medudy Expert Opinion with Prof. Sherko Kümmel is a video tutorial for physicians on the topic of "Treatment of metastatic triple-negative breast cancer (TNBC)". The content first highlights the historical situation in 2018, in which the prognosis for high-risk tumor biology was very poor and the median overall survival time was only 12 to 15 months. The [...]
Part 4 Practical tips for dealing with side effects of immunotherapy
This Medudy Expert Opinion with Prof. Sherko Kümmel is a video tutorial for physicians on the topic of "Practical tips for dealing with side effects of immunotherapy in triple-negative breast cancer". A comparison is made between the side effect profiles of chemotherapy and immunotherapy, emphasizing the higher variability and the involvement of different organ systems under immunotherapy. [...]
Part 3 Open questions - Triple-negative early breast cancer (eTNBC)
This Medudy Master Class Series is a video tutorial for physicians on the topic "Treatment of Triple-negative breast cancer (TNBC) in stage II and III with a focus on the role of immunotherapy", presented by Prof. Sherko Kümmel This episode deals in detail with the current treatment standards and central questions in this early stage of [...]
Part 2 Stage II+III - TNBC Focus: Role of immunotherapy
This Medudy Master Class Series is a video tutorial for physicians on the topic "Treatment of Triple-negative breast cancer (TNBC) in stage II and III with a focus on the role of immunotherapy", presented by Prof. Sherko Kümmel This episode deals in detail with the current treatment standards and central questions in this early stage of [...]